The National Institute of General Medical Sciences (NIGMS) awarded a $3,183,750 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Boise State University. The grant, titled "CENTER OF BIOMEDICAL RESEARCH EXCELLENCE IN MATRIX BIOLOGY PHASE 3", will support the university's multidisciplinary research center focused on improving understanding of the role of the extracellular matrix (ECM) in development, health, and disease. The funding will sustain research core facilities, provide career development opportunities, and continue the center's efforts to advance ECM-related research in areas such as breast cancer metastasis, ligament healing, liver fibrosis, cardiovascular health, and neuroinflammation. This Phase 3 award, with a performance period from August 1, 2024 to May 31, 2029, builds upon the center's accomplishments in the previous two phases, which have included establishing a multidisciplinary research team, securing external grant funding, and developing state-of-the-art core facilities to support the ECM-focused research program.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $1.1m | 6/13/25 | ||
| Not listed | $1.1m | 7/25/24 | ||
| Not listed | $1.1m | 7/25/24 |